Extended Drug Therapy for Hepatitis Is Challenged, St. Louis University Study
MedPage Today -- ST. LOUIS, Dec. 3 -- Final results are in for a landmark study of long-term peginterferon for patients with chronic hepatitis C that isn't responsive to therapy.